Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.
Sima
Anders A F
AA
Departments of Pathology and Neurology, Wayne State University School of Medicine, Detroit, MI 48201, USA. asima@med.wayne.edu
D000818:Animals; D002096:C-Peptide / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology; D004195:Disease Models, Animal; D006801:Humans; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D002096:C-Peptide; D019001:Nitric Oxide Synthase; D000254:Sodium-Potassium-Exchanging ATPase